Patients with Uveal Melanoma Tested with DecisionDx®-UM Report Gaining Value from Test Results In Study Conducted In Collaboration with the Melanoma Research Foundation’s CURE OM Initiative

Data shows patients surveyed had low decision regret1 after testing with DecisionDx®-UM, regardless of whether their uveal melanoma tumor was at high or low risk of metastasis FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced findings from a study that evaluated uveal … [Read more…]

Astrotech Appoints Jim Becker to Board of Directors

AUSTIN, Texas–(BUSINESS WIRE)–Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors. Mr. Becker brings to Astrotech’s Board extensive leadership, with a focus on strategic market growth and expansion, and business process improvements and scaling, along with public speaking and corporate management skills. He will serve on each … [Read more…]

Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry … [Read more…]

VistaGen Therapeutics Reports Fiscal Year 2022 Financial Results and Provides Corporate Update

Completed last patient out milestone for PALISADE-1 Phase 3 clinical trial of PH94B in social anxiety disorder (SAD). Topline results for PALISADE-1 anticipated mid-2022. PALISADE-2 on track for topline readout in late 2022. Received FDA consensus that data from nonclinical and clinical studies of PH94B completed to date provide no signal of abuse potential. SOUTH … [Read more…]

Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), anticipates releasing topline data from Part A of its ongoing Phase 2 study of ANEB-001 on July 5th. The results of the study, conducted in … [Read more…]

Zillion’s Restore Coach Institute is Now an Approved Health and Wellness Coach Training and Education Program by the National Board of Health and Wellness Coaching (NBHWC)

The employee health and wellness leader’s coaching graduates are now eligible to apply for the HWC Certifying Examination to become National Board Certified Health & Wellness Coach (NBC-HWC). NORWALK, Conn.–(BUSINESS WIRE)–#behavioralhealth—Zillion and its coaching team is proud to announce that the National Board for Health and Wellness Coaching (NBHWC) has approved Zillion’s Restore Coach Institute … [Read more…]

First-ever CA State Fair Cannabis Awards & Competition Announces Winners

Historic Moment for California’s Cannabis Industry SACRAMENTO, Calif.–(BUSINESS WIRE)–#cannabis–The CA State Fair Cannabis Awards today announced the inaugural award-winning cultivars and cultivators from throughout California. More than 300 entries were evaluated for this year’s competition. A total of 60 trophies and medals were awarded, consisting of gold and silver medals by division and category, as … [Read more…]

Avita Adds Two New Members to Board of Directors

HIV and LGBTQ+-focused health care services organization adds former U.S. surgeon general and industry leader to gain public health expertise and insight. PLANO, Texas–(BUSINESS WIRE)–Avita, the leading HIV-focused pharmacy services organization in the nation, today announced the appointment of two new members to its Board of Directors, effective July 1: Jerome Adams, MD, MPH, FASA, … [Read more…]

Tevogen Bio Appoints Distinguished Clinician and Former Matheny President and CEO, Dr. Kendell R. Sprott, to Corporate Advisory Board

Tevogen’s Corporate Advisory Board represents renowned experts from all sectors of the healthcare system, academia, financial industry, and patient advocates to provide guidance as the company continues to expand its genetically unmodified precision T cell platform technology. WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio, a late-stage biotechnology company specializing in developing cell and gene therapies in oncology, neurology, … [Read more…]

Rasmussen University Launches Three New Master of Science in Nursing – Nurse Practitioner (MSN–NP) Specializations in Pediatric, Adult Gerontology and Family Care

Designed for working nurses, the new MSN-NP specializations to help fill a growing healthcare demand MINNEAPOLIS–(BUSINESS WIRE)–#highered–Rasmussen University, a university accredited by the Higher Learning Commission1, announced today the launch of three new CCNE-accredited2 Master of Science in Nursing – Nurse Practitioner specializations including Pediatric Primary Care, Adult-Gerontology Primary Care and Family.* Rasmussen is launching … [Read more…]